Neogen Stock

Neogen EBIT

The EBIT of Neogen (NEOG) as of Jun 16, 2026 is -1.68 T USD.In the previous year, EBIT was 74.18 T USD — a change of -102.26% (lower).

EBIT

-1.68 TUSD

YoY

-102.26%

Last updated:

In 2026, Neogen's EBIT was -1.68 T USD, a -102.26% increase from the 74.18 T USD EBIT recorded in the previous year.

The Neogen EBIT history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT (M USD)
Date
EBIT (M USD)
Jan 1, 2006
10.8 base
Jan 1, 2007
13.5 base
Jan 1, 2008
18 base
Jan 1, 2009
20.5 base
Jan 1, 2010
26.9 base
Jan 1, 2011
35.8 base
Jan 1, 2012
33.7 base
Jan 1, 2013
40.7 base
Jan 1, 2014
43.4 base
Jan 1, 2015
53.1 base
Jan 1, 2016
56.4 base
Jan 1, 2017
64.9 base
Jan 1, 2018
70.2 base
Jan 1, 2019
68.1 base
Jan 1, 2020
67.5 base
YEAREBIT (M USD)
2030 est 11.53
2029 est 9.28
2028 est 36.98
2027 est 23.04
2026 est -25.63
2025 -1.68
2024 74.18
2023 97.3
2022 58.6
2021 74.2
2020 67.5
2019 68.1
2018 70.2
2017 64.9
2016 56.4
2015 53.1
2014 43.4
2013 40.7
2012 33.7
2011 35.8
2010 26.9
2009 20.5
2008 18
2007 13.5
2006 10.8
Access this data via the Eulerpool API

Neogen Revenue

Neogen Revenue, EBIT, Net Income

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details
Date
Revenue
EBIT
Net Income
Jan 1, 2006
72.4 M USD
10.8 M USD
7 M USD
Jan 1, 2007
86.1 M USD
13.5 M USD
9.1 M USD
Jan 1, 2008
102.4 M USD
18 M USD
12.1 M USD
Jan 1, 2009
118.7 M USD
20.5 M USD
13.9 M USD
Jan 1, 2010
140.5 M USD
26.9 M USD
17.5 M USD
Jan 1, 2011
172.7 M USD
35.8 M USD
22.8 M USD
Jan 1, 2012
184 M USD
33.7 M USD
22.5 M USD
Jan 1, 2013
207.5 M USD
40.7 M USD
27.2 M USD
Jan 1, 2014
247.4 M USD
43.4 M USD
28.2 M USD
Jan 1, 2015
283.1 M USD
53.1 M USD
33.5 M USD
Jan 1, 2016
321.3 M USD
56.4 M USD
36.6 M USD
Jan 1, 2017
358.3 M USD
64.9 M USD
43.8 M USD
Jan 1, 2018
397.9 M USD
70.2 M USD
63.1 M USD
Jan 1, 2019
414.2 M USD
68.1 M USD
60.2 M USD
Jan 1, 2020
418.2 M USD
67.5 M USD
59.5 M USD

Neogen Margins

Neogen stock margins

The Neogen margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Neogen. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Neogen.
  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details
Date
Gross margin
EBIT margin
Profit margin
Jan 1, 2006
51.1 %
14.92 %
9.67 %
Jan 1, 2007
51.8 %
15.68 %
10.57 %
Jan 1, 2008
51.95 %
17.58 %
11.82 %
Jan 1, 2009
50.04 %
17.27 %
11.71 %
Jan 1, 2010
51.96 %
19.15 %
12.46 %
Jan 1, 2011
50.84 %
20.73 %
13.2 %
Jan 1, 2012
50.22 %
18.32 %
12.23 %
Jan 1, 2013
52.77 %
19.61 %
13.11 %
Jan 1, 2014
49.56 %
17.54 %
11.4 %
Jan 1, 2015
49.35 %
18.76 %
11.83 %
Jan 1, 2016
47.65 %
17.55 %
11.39 %
Jan 1, 2017
47.14 %
18.11 %
12.22 %
Jan 1, 2018
46.82 %
17.64 %
15.86 %
Jan 1, 2019
46.33 %
16.44 %
14.53 %
Jan 1, 2020
46.94 %
16.14 %
14.23 %

Neogen Stock analysis

What does Neogen do? Neogen Corp is a leading provider of food safety and animal health solutions based in Lansing, Michigan, USA. The company was founded in 1982 by James Herbert and initially focused on the development and manufacturing of rapid tests for the dairy industry. Since then, Neogen has become an internationally operating company with over 25 subsidiaries and 1,800 employees. Neogen's business model is based on providing solutions for safe and healthy food supply and animal husbandry. The company operates in two main divisions: Food Safety and Animal Safety. Within these divisions, Neogen offers a wide range of test kits, diagnostic tools, information management software, and other products that help minimize the risk of food poisoning and improve the health of livestock. In the Food Safety division, Neogen offers a variety of test kits that allow food producers and retailers to quickly and easily detect various types of contaminants in food. These include tests for salmonella, E. coli, listeria, and mycotoxins. The company also provides tools for monitoring water quality and verifying cleaning and disinfection processes in food processing plants. In the Animal Safety division, Neogen also offers an extensive range of diagnostic tools to improve the health of livestock. The tests include infectious diseases such as brucellosis, BSE (mad cow disease), mastitis, and leukemia. Additionally, Neogen provides tools for animal identification and animal health data management. Neogen has also specialized in the development of technologies to improve animal health and nutrition, such as probiotics and supplements for livestock. Another focus of Neogen is the development of information management software that enables food producers and retailers to streamline the process of food safety and quality. The software allows companies to track tests, analyze data, and implement best practices to minimize the risk of food poisoning. In recent years, Neogen has also increasingly focused on the global market, especially the Asian market. The company has subsidiaries in various parts of the world, including Europe, Latin America, and Asia. Neogen works closely with local regulatory authorities to offer its products in accordance with local requirements. In conclusion, Neogen Corp is a leading provider of food safety and animal health solutions, focusing on the development and manufacturing of test kits, diagnostic tools, and information management software. The company has experienced impressive growth in recent decades and is now operating internationally. With its commitment to safe and healthy food supply and animal husbandry, Neogen sets industry standards. Neogen is one of the most popular companies on Eulerpool.

EBIT Details

Analyzing Neogen's EBIT

Neogen's Earnings Before Interest and Taxes (EBIT) represents the company's operating profit. It is calculated by deducting all operating expenses, including the cost of goods sold (COGS) and operating expenses, from the total revenue, but before accounting for interest and taxes. It provides insights into the company’s operational profitability, excluding the impacts of financing and tax structures.

Year-to-Year Comparison

A yearly comparison of Neogen's EBIT can reveal trends in the company’s operational efficiency and profitability. An increase in EBIT over the years can indicate enhanced operational efficiency or growth in revenue, while a decrease might raise concerns about increased operating costs or declining sales.

Impact on Investments

Neogen's EBIT is a significant metric for investors. A positive EBIT suggests that the company is generating enough revenue to cover its operating expenses, an essential aspect for assessing the company’s financial health and stability. Investors closely monitor EBIT to gauge the company’s profitability and potential for future growth.

Interpreting EBIT Fluctuations

Fluctuations in Neogen’s EBIT can be due to variations in revenue, operating expenses, or both. An increasing EBIT indicates improved operational performance or increased sales, while a declining EBIT can signal rising operational costs or reduced revenue, prompting a need for strategic adjustments.

Frequently Asked Questions about Neogen stock

EBIT of Neogen amounted to 74.18 T USD -1.68 T

The sales revenue is important for evaluating a stock.

EBIT is an acronym for "Earnings Before Interest and Tax" and represents a company's gross profit before taxes and interest are deducted. The EBIT amount is often used as a metric to evaluate a company.

History

The EBIT was originally introduced in the 1940s when the US Internal Revenue Service (IRS) passed a new tax law. This law required companies to calculate their profit before deducting taxes and interest on loans (or "interest and taxes"). Since then, the EBIT has been used as one of the key financial indicators in evaluating a company.

Usage

The EBIT can be used to assess a company by comparing its financial results to a benchmark or a comparative value. The EBIT is also used to determine how much the company's shareholders will receive from its operating income.

Calculation

EBIT is calculated by deducting taxes and interest on loans from the company's net profit. This amount can be calculated in various ways, but the most common method is as follows:

EBIT = Net profit + interest and taxes

Example: Eulerpool: Your source for quantitative stock data At Eulerpool, we are dedicated to providing you with comprehensive and accurate stock information. Our website offers a wide range of tools and features, including charts, stock lists, and more. Whether you are an experienced investor or just starting out, our platform is designed to meet your needs. With our in-depth analytics and algorithms, you can make informed decisions and stay ahead of the market. Explore our extensive collection of stocks, track their performance, and access real-time data. With Eulerpool, you can easily navigate the world of finance and monitor the stocks that matter to you. Join our community today and gain valuable insights into the world of stocks and investments. Sign up for free and discover the power of Eulerpool. Stay informed. Stay ahead. Eulerpool - your trusted partner in stock data.
Net profit of XYZ Co. = $1,000,000
Interest and taxes = $ 500,000
EBIT of XYZ Co. = $1,500,000

Application

The EBIT value is often used to determine and evaluate the financial stability of a company. The EBIT value can also be used to determine how much money a company can spend on investments or dividends.

Use of EBIT in stock investment

Investors use EBIT to determine if a stock is over- or undervalued. If a company has a high EBIT value, it may indicate that its stock is overvalued, as the profit it generates could be lower than what it would generate with a different stock.

Advantages of EBIT

EBIT is a helpful measure for determining the financial stability of a company. There are several advantages associated with using EBIT, such as:
- EBIT eliminates the impact of financing on the company's earnings.
- It is a useful measure for determining the profits that a company can distribute to its shareholders.
- It can be used to determine whether a stock is overvalued or undervalued.

Disadvantages of EBIT

There are also some disadvantages to using EBIT, such as:
- EBIT cannot be used as the sole measure to evaluate a company as it does not reflect the overall profit of the company.
- EBIT can be influenced by unforeseen events such as a tax increase.
- EBIT is not always a reliable indicator of a company's future profit development.

Conclusion

The EBIT is an important measure used to evaluate a company. It can be used to determine how much money a company can generate from its operational results and whether a stock is overvalued or undervalued. However, the EBIT also has some disadvantages as it does not reflect the overall profitability of a company and can be influenced by unforeseen events. Therefore, it is important to consider the EBIT in conjunction with other financial indicators to obtain a complete picture of the company.

Access this data via the Eulerpool API

Income Statement — Neogen

All Key Metrics — Neogen